News & Updates
Filter by Specialty:
Tenofovir alafenamide safe to use in breastfeeding mothers with CHB
The first human pharmacokinetic study of tenofovir alafenamide (TAF; commercially sold as Vemlidy) monotherapy in breastfeeding women with chronic hepatitis B (CHB) has found low concentrations of TAF and tenofovir in the breastmilk, with negligible exposure to infants.
Tenofovir alafenamide safe to use in breastfeeding mothers with CHB
16 Nov 2021
Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
Higher intake of alcohol and reduced care during the COVID-19 pandemic have triggered a spike in alcohol-related liver diseases, leading to some serious consequences, according to new research.
Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
15 Nov 2021
Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
Statin reduces the risk of cardiovascular disease and mortality in type 2 diabetes, and this beneficial effect is evident among middle-aged and, to a lesser extent, older patients but not among young patients, a study has found.
Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
14 Nov 2021
Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
In the treatment of adults with uncontrolled focal seizures, the long-term, open-label use of cenobamate appears to produce high rates of sustained 100-percent and ≥90-percent seizure reduction, with parallel decreases in concomitant antiseizure medication (ASM) doses, according to two separate post hoc analyses of a phase III C021 trial.
